Amarillo Biosciences, Inc. (AMAR) - Financial and Strategic SWOT Analysis Review

Date: September 20, 2016
Pages: 37
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: A52FDF8DF2FEN
Leaflet:

Download PDF Leaflet

Amarillo Biosciences, Inc. (AMAR) - Financial and Strategic SWOT Analysis Review
Amarillo Biosciences, Inc. (AMAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Amarillo Biosciences, Inc. (ABI) is a specialty biopharmaceutical company, which focuses on the development of biologics for the treatment of human and animal diseases. It develops innovative therapeutic candidates for the treatment of human disease indications such as influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon alpha. Its product portfolio includes a dietary supplement product, Maxisal to treat dryness of mouth. The company utilizes injectable interferon, an FDA-approved technology to develop drugs for the treatment of neoplastic, viral and autoimmune diseases. It has development partners in China and Taiwan, Japan, Malaysia, India and Nepal. ABI is headquartered in Amarillo, Texas, the US.

Amarillo Biosciences, Inc. Key Recent Developments

May 18, 2015: Amarillo Biosciences Summarizes New Plan of Operation

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Amarillo Biosciences, Inc. - Key Facts
Amarillo Biosciences, Inc. - Key Employees
Amarillo Biosciences, Inc. - Key Employee Biographies
Amarillo Biosciences, Inc. - Major Products and Services
Amarillo Biosciences, Inc. - Pharmaceutical Pipeline Products Data
Amarillo Biosciences, Inc., Pipeline Products by Therapy Area
Amarillo Biosciences, Inc., Pipeline Products by Development Phase
Amarillo Biosciences, Inc. - History
Amarillo Biosciences, Inc. - Company Statement
Amarillo Biosciences, Inc. - Locations And Subsidiaries
Head Office

SECTION 2 – COMPANY ANALYSIS

Amarillo Biosciences, Inc. - Business Description
Amarillo Biosciences, Inc. - Corporate Strategy
Amarillo Biosciences, Inc. - SWOT Analysis
SWOT Analysis - Overview
Amarillo Biosciences, Inc. - Strengths
Strength - Strong Patent Portfolio
Strength - Proprietary Technology
Strength - Research and Development Activities
Amarillo Biosciences, Inc. - Weaknesses
Weakness - Competitive Positioning
Weakness - Lack of Marketed Products
Amarillo Biosciences, Inc. - Opportunities
Opportunity - Potential Market: Influenza
Opportunity - Reorganization Plan
Opportunity - HCV Market Potential
Amarillo Biosciences, Inc. - Threats
Threat - Intense Competition
Threat - Reliance on Third Party Manufacturers
Threat - Intellectual Property Risk
Amarillo Biosciences, Inc. - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Amarillo Biosciences, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Amarillo Biosciences, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Amarillo Biosciences, Inc., Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

May 18, 2015: Amarillo Biosciences Summarizes New Plan of Operation

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Amarillo Biosciences, Inc., Key Facts
Amarillo Biosciences, Inc., Key Employees
Amarillo Biosciences, Inc., Key Employee Biographies
Amarillo Biosciences, Inc., Major Products and Services
Amarillo Biosciences, Inc., Number of Pipeline Products by Therapy Area
Amarillo Biosciences, Inc., Number of Pipeline Products by Development Stage
Amarillo Biosciences, Inc., Pipeline Products By Therapy Area and Development Phase
Amarillo Biosciences, Inc., History
Amarillo Biosciences, Inc., Key Competitors
Amarillo Biosciences, Inc., Ratios based on current share price
Amarillo Biosciences, Inc., Annual Ratios
Amarillo Biosciences, Inc., Interim Ratios
Amarillo Biosciences, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Amarillo Biosciences, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Amarillo Biosciences, Inc., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Amarillo Biosciences, Inc., Pipeline Products by Therapy Area
Amarillo Biosciences, Inc., Pipeline Products by Development Phase
Amarillo Biosciences, Inc., Performance Chart (2011 - 2015)
Amarillo Biosciences, Inc., Ratio Charts
Amarillo Biosciences, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Amarillo Biosciences, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016

COMPANIES MENTIONED

InterMune, Inc.
Hoffmann-La Roche Inc.
Hemispherx Biopharma, Inc.
Skip to top


Ask Your Question

Amarillo Biosciences, Inc. (AMAR) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: